Consistent with our study, previous studies had demonstrated that the pro-CTSD/act-CTSD ratio was significantly increased in NAFLD mice and cell models of different backgrounds, which was parallel with impaired lysosomal acidification [47]. The gene discussed is CTSD; the disease is metabolic dysfunction-associated steatotic liver disease.